STONE DAVID K 4
4 · GENOME THERAPEUTICS CORP · Filed Jan 21, 2004
Insider Transaction Report
Form 4
STONE DAVID K
Director
Transactions
- Award
Stock Options
2004-01-15+174→ 86,087 totalExercise: $1.54From: 2004-01-15Exp: 2014-01-15→ Common Shares (174 underlying)